Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Nat Commun ; 13(1): 2219, 2022 04 25.
Artigo em Inglês | MEDLINE | ID: mdl-35468907

RESUMO

The genome-editing Cas9 protein uses multiple amino-acid residues to bind the target DNA. Considering only the residues in proximity to the target DNA as potential sites to optimise Cas9's activity, the number of combinatorial variants to screen through is too massive for a wet-lab experiment. Here we generate and cross-validate ten in silico and experimental datasets of multi-domain combinatorial mutagenesis libraries for Cas9 engineering, and demonstrate that a machine learning-coupled engineering approach reduces the experimental screening burden by as high as 95% while enriching top-performing variants by ∼7.5-fold in comparison to the null model. Using this approach and followed by structure-guided engineering, we identify the N888R/A889Q variant conferring increased editing activity on the protospacer adjacent motif-relaxed KKH variant of Cas9 nuclease from Staphylococcus aureus (KKH-SaCas9) and its derived base editor in human cells. Our work validates a readily applicable workflow to enable resource-efficient high-throughput engineering of genome editor's activity.


Assuntos
Proteínas de Bactérias , Sistemas CRISPR-Cas , Proteínas de Bactérias/metabolismo , Sistemas CRISPR-Cas/genética , DNA/metabolismo , Humanos , Aprendizado de Máquina , Mutagênese
2.
Nucleic Acids Res ; 50(3): 1650-1660, 2022 02 22.
Artigo em Inglês | MEDLINE | ID: mdl-35051997

RESUMO

The Cas9 nuclease from Staphylococcus aureus (SaCas9) holds great potential for use in gene therapy, and variants with increased fidelity have been engineered. However, we find that existing variants have not reached the greatest accuracy to discriminate base mismatches and exhibited much reduced activity when their mutations were grafted onto the KKH mutant of SaCas9 for editing an expanded set of DNA targets. We performed structure-guided combinatorial mutagenesis to re-engineer KKH-SaCas9 with enhanced accuracy. We uncover that introducing a Y239H mutation on KKH-SaCas9's REC domain substantially reduces off-target edits while retaining high on-target activity when added to a set of mutations on REC and RuvC domains that lessen its interactions with the target DNA strand. The Y239H mutation is modelled to have removed an interaction from the REC domain with the guide RNA backbone in the guide RNA-DNA heteroduplex structure. We further confirmed the greatly improved genome-wide editing accuracy and single-base mismatch discrimination of our engineered variants, named KKH-SaCas9-SAV1 and SAV2, in human cells. In addition to generating broadly useful KKH-SaCas9 variants with unprecedented accuracy, our findings demonstrate the feasibility for multi-domain combinatorial mutagenesis on SaCas9's DNA- and guide RNA- interacting residues to optimize its editing fidelity.


Assuntos
Proteína 9 Associada à CRISPR/genética , Edição de Genes , Staphylococcus aureus , Sistemas CRISPR-Cas , Humanos , Nuclease do Micrococo/genética , RNA Guia de Cinetoplastídeos , Staphylococcus aureus/genética
3.
Cell Rep ; 32(6): 108020, 2020 08 11.
Artigo em Inglês | MEDLINE | ID: mdl-32783942

RESUMO

We present a CRISPR-based multi-gene knockout screening system and toolkits for extensible assembly of barcoded high-order combinatorial guide RNA libraries en masse. We apply this system for systematically identifying not only pairwise but also three-way synergistic therapeutic target combinations and successfully validate double- and triple-combination regimens for suppression of cancer cell growth and protection against Parkinson's disease-associated toxicity. This system overcomes the practical challenges of experimenting on a large number of high-order genetic and drug combinations and can be applied to uncover the rare synergistic interactions between druggable targets.


Assuntos
Sistemas CRISPR-Cas , Combinação de Medicamentos , Sistemas de Liberação de Medicamentos/métodos , Ensaios de Triagem em Larga Escala/métodos , Animais , Antineoplásicos/farmacologia , Drosophila melanogaster , Técnicas de Inativação de Genes , Células HEK293 , Humanos , Camundongos , Neoplasias/tratamento farmacológico , Doença de Parkinson/tratamento farmacológico , RNA Guia de Cinetoplastídeos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA